(LifeSiteNews) — Washington state’s department of health sparked backlash Friday for reminding “transmasculine persons with a cervix” — better known as “women” — to get screened for cervical cancer.
“Transmasculine persons with a cervix should talk to their doctor about #CervicalCancer screening and the #HPVvax,” the government agency’s official Twitter account said in a January 13 tweet.
The message directed viewers to “Find a LGBTQ-welcoming provider” by following a link to the National LGBT Cancer Network.
— WA Dept. of Health (@WADeptHealth) January 13, 2023
“If you have a cervix you are a female of either the girl/woman variety,” one Twitter user wrote. “There is no other option except in your imagination. Depts of Health should know better than to pander to imaginary whims.”
Though social media users were quick to point out the absurdity of the transgender ideology expressed in the state agency’s message, people who have undergone surgeries and pharmaceutical interventions to look more like the opposite gender tend to experience higher rates of cancer due to their lifestyles.
The resource cited by the Washington Department of Health states on its website that one of its primary goals is to educate “the LGBT community about” its “increased cancer risks and the importance of screening and early detection.”
A 2017 analysis published by the National Institutes of Health (NIH)’s National Center for Biotechnology Information (NCBI) noted that “As cross-sex hormones administered for the purposes of gender affirmation may be delivered at high doses and over a period of decades, the carcinogenicity of hormonal therapy in transgender people is an area of considerable concern.”
“In addition, concerns about cancer risk in transgender patients have been linked to sexually transmitted infections, increased exposure to well-known risk factors such as smoking and alcohol use, and the lack of adequate access to screening,” the analysis suggested.
Studies conducted in recent years have further borne out worries about increased cancer risk for gender-confused people who pursue pharmaceutical interventions.
A 2019 study published in the British Medical Journal found that men who took hormones to look more like women were more than 46 times more likely to be diagnosed with breast cancer, LifeSiteNews previously reported.
Researchers have also observed a higher incidence of cancer in gender-confused women.
A March 2020 study published by Cancer, a medical journal, discovered that gender-confused women “are twice as likely as cisgender men [biological men] to have had cancer,” Boston University’s School of Public Health pointed out.
“The researchers also found that, among cancer survivors, trans men [gender-confused women] had the worst overall health, and were nine times more likely to have diabetes and heart disease than cisgender women, seven times more likely to have diabetes than cis men [sic], and four times more likely to have cardiovascular disease than cis men [sic],” Boston University noted.
In addition to cancer risks, transgender surgeries and drugs can also cause infertility in children and adults.
Late last year, board-certified pediatrician Dr. Kathryn Lowe told the Wisconsin chapter of the American Academy of Pediatrics (AAP) that children who take puberty blockers in combination with cross-sex hormones “probably will be infertile.”
“The big thing is, here, the infertility concerns with starting gender affirming hormone therapy,” Lowe said in the video. “For kids who go on a blocker at tanner stage two, and then they add in gender affirming hormone therapy—there isn’t a lot of research about this out there—but what we do know is these kids probably will be infertile.”